About the Company
We do not have any company description for Adaptive Biotechnologies Corp at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?
Shares of Adaptive Biotechnologies (ADPT) have been strong performers lately, with the stock up 14.5% over the past month. The stock hit a new 52-week high of $12.93 in the previous session. Adaptive ...
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview ...
Adaptive Biotechnologies Corp (NASDAQ:ADPT) is set to release its Q4 2024 earnings on Feb 11, 2025. The consensus estimate for Q4 2024 revenue is $46.03 million, and the earnings are expected to ...
Adaptive Biotechnologies Corporation to Announce Second ... - Nasdaq
Adaptive Biotechnologies Corporation announced it will release its second quarter 2025 financial results on August 5, 2025, after market close, followed by a conference call at 1:30 p.m. Pacific Time.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings ...
A week ago, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) came out with a strong set of first-quarter numbers that could potentially lead to a re-rate of the stock. Revenue crushed ...
Adaptive Biotechnologies Corporation (ADPT) Q4 2024 Earnings Call ...
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Q4 2024 Results Conference Call February 11, 2025 4:30 PM ET Company Participants Karina Calzadilla - Head of IR & FP&A Chad Robins - CEO and Co ...
Here’s Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4
One-month return of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) was -8.84%, and its shares lost 54.84% of their value over the last 52 weeks.
Adaptive Biotechnologies Corp. - MarketWatch
Adaptive Biotechnologies Corp. Annual stock financials by MarketWatch. View the latest ADPT financial statements, income statements and financial ratios.
Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results
The one-month return of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) was -3.19%, and its shares gained 145.48% of their value over the last 52 weeks.
Commit To Buy Adaptive Biotechnologies Corp At $2.50, Earn 9.3% ...
Investors eyeing a purchase of Adaptive Biotechnologies Corp (Symbol: ADPT) shares, but cautious about paying the going market price of $3.60/share, might benefit from considering selling puts ...
Adaptive Biotechnologies Corp ADPT - Morningstar
Review Adaptive Biotechnologies Corp (ADPT:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
ADPT - Adaptive Biotechnologies Corp Executives | Morningstar
Learn about the executive team and board of directors at Adaptive Biotechnologies Corp (ADPT:XNAS) and review their bios and compensation over the latest fiscal years.
Similar Companies
Loading the latest forecasts...